“6-Month Checkup”的搜索结果，显示 731-740 项，共有 14489 项

1. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

2. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to learn about how platelets adhere to the blood von Willebrand factor and how known clinical mutations that ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 6 standard of care (SOC) chemotherapy regimens for the treatment of advanced colorectal carcinoma. The primary study hypothesis is that pembrolizumab will ...

5. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

6. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

7. 外科 - 临床试验- 妙佑医疗国际

   Go to page 66 · Go to page 77 · NextNext Page. 以下为当前的临床试验。 101 研究外科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 A Study to Explore ...

8. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This clinical trial is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies. Developing a ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...